Pel-Freez Biologicals

Executive Summary

Pel-Freez Biologicals is a privately-held, established supplier of high-quality biological reagents derived from human and animal sources. Founded in 1947 and headquartered in Rogers, Arkansas, the company serves research laboratories, diagnostic manufacturers, and vaccine developers with a focus on consistency and ethical sourcing. Its core product lines include blood products, complement, sera, tissues, and antibodies. The company’s long history and customer relationships provide a stable revenue base, but its private status and lack of disclosed financials make it difficult to assess growth trajectory. The demand for biological reagents is steady, driven by ongoing research and diagnostics needs, but Pel-Freez faces competition from larger life science suppliers. The company's conviction score is moderate given its niche market position and lack of public catalysts.

Upcoming Catalysts (preview)

• Q4 2026Expansion of custom antibody services to meet growing demand from biopharma60% success
• Q2 2027Launch of new cell-based reagents for vaccine development50% success
• TBDPotential strategic partnership or acquisition by a larger life sciences firm30% success